Bittium Corporation
Other information disclosed according to the rules of the Exchange

A One-off Matching Share Plan for The CEO of Bittium Corporation and Transfer of Own Shares

Bittium Corporation, Stock Exchange Release, 15 May 2025, at 7.00 pm (CEST+1)

The Board of Directors of Bittium Corporation has today decided on the establishment of a one-off matching share plan for the Chief Executive Officer (CEO) of the company (below the "Plan"). 

The aim of the Plan is through share ownership to align the interests of the CEO with those of the company's shareholders and thereby to promote shareholder value creation in the long term as well as the retention of the CEO with the company.

The matching share plan is a one-off plan, in which the CEO is expected to make an investment of approximately EUR 100,000 in shares of Bittium Corporation. Bittium Corporation will match the share investment by way of delivering matching shares without consideration with a net value of EUR 100,000 to the CEO.  

The share investment is carried out by way of a transfer of own shares against consideration to the CEO (a directed share issue against consideration). The subscription price payable for the shares is based on the volume-weighted average price of the share of Bittium Corporation formed in public trading on Nasdaq Helsinki after the publication date of Bittium Corporation's Business Review January-March 2025 during the period 30 April - 13 May 2025. The subscription price so formed for the shares is 6.69 euro per share and, based thereon, the number of shares offered for subscription by the CEO 14,949 shares.   

The shares are offered for subscription by the CEO immediately, however, within seven days from the date of the above-mentioned decision of the Board of Directors at the latest. The CEO has today subscribed all the abovementioned shares which were offered for subscription.

The delivery of the matching shares to the CEO based on the Plan is carried out by way of transferring own shares without consideration (a directed share issue without consideration). The number of matching shares is determined based on the same above-mentioned average price and is 14,949 shares. The matching shares are delivered within fourteen days from the date the CEO made and paid the above-mentioned share subscription against payment. The CEO having today made that respective share investment, the matching shares have been delivered to him today in accordance with the Plan. In addition to the matching shares, the company pays the payroll tax and other taxes and tax-like charges payable in connection with the Plan.  

The matching shares delivered to the CEO will be subject to a transfer restriction of two years.

There is an especially weighty financial reason for the company, also taking into account the interests of all the company's shareholders, to deviate from the shareholders' pre-emptive subscription right both in the directed share issue against and in that without consideration. They form a matching share plan for the CEO the aim of which is through share ownership to align the interests of the CEO with those of the company's shareholders and thereby to promote shareholder value creation in the long term as well as the retention of the CEO with the company.

Bittium Corporation, after the abovementioned share transfers holds 186,228 own shares. After the implementation of the Plan the shareholding of the CEO in Bittium Corporation is 57,863 shares.

Oulu, 15 May 2025

Bittium Corporation
The Board of Directors

Further information:

Kari Jokela
CLO
Tel. +358 40 344 2789 (group communications)

Distribution

Nasdaq Helsinki Oy
Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 40-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology and neurophysiology. Net sales in 2024 were EUR 85.2 million and operating profit was EUR 8.6 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com